Brain Control of Bimanual (Both Hands) Movements

Brain Areas Involved in Temporal Linkage of Bilateral Movements

This study will use magnetic resonance imaging (MRI) to investigate how the brain controls bimanual movements (movements of both hands).

Healthy normal volunteers between 21 and 65 years of age may be eligible for this study.

Participants will have a medical history, physical and neurological examinations, and will complete a questionnaire before and after testing. The study consists of two parts: 1) finger movement training and 2) magnetic resonance imaging, as follows:

Part 1 - Finger movement training

Participants will train to do three different finger movements using the index finger of both hands. The fingers will be taped to a device that measures their movement. The movements are:

  • Lifting and dropping the index fingers of each hand repetitively and in synchrony (starting and stopping at the same time). The amplitude of finger movements is the same for both hands.
  • Lifting and dropping the index fingers of each hand repetitively and in synchrony, but with a different amplitude for each hand.
  • Lifting and dropping of the index finger of each hand repetitively, but each with a different amplitude and not in synchrony.

Part 2 - Magnetic resonance imaging

Participants will perform the trained movements during MRI scanning. This diagnostic procedure uses a magnetic field and radio waves to produce images of brain structure and activity. For MRI, the subject lies on a stretcher that is moved into the scanner-a cylinder containing a strong magnet. Earplugs are worn to protect the ears from loud thumping noises that occur with electrical switching of radio frequency circuits. Scanning time varies from 20 minutes to 2 hours, with most examinations lasting 1 to 1 1/2 hours. The subject can communicate with the staff person conducting the test at all times during the scan.

Study Overview

Status

Completed

Conditions

Detailed Description

OBJECTIVE: The present study is aimed to clarify which structure or network of structures are responsible for the temporal linkage in bimanual co-ordination in healthy humans.

STUDY POPULATION: Healthy normal volunteers.

DESIGN:

fMRI: Anatomical MRI and fMRI sequences are performed to obtain blood-oxygenation level-dependent (BOLD) imaging of brain activation during which movement performance will be measured with respect to movement synchrony, movement speed and amplitude.

Multi-channel EEG recording performed while motor performance is monitored.

OUTCOME MEASURES:

fMRI: BOLD will be obtained using baseline correction.

EEG: band-power and inter-regional coherence will be calculated using baseline correction.

Study Type

Observational

Enrollment

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Bethesda, Maryland, United States, 20892
        • National Institutes of Health Clinical Center, 9000 Rockville Pike

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

  • INCLUSION CRITERIA:

    1. Forty normal volunteers ranging from 21 to 75 will be included. Normal volunteers would be recruited from people who are registered as HMCS Normal Volunteers. All subjects should have a valid Clinical Center Medical Record Number.
    2. Alcohol abstention is required for all subjects for both fMRI and EEG for 24 hours before the study.

EXCLUSION CRITERIA:

  1. Normal subjects younger than 21 years and older than 75 will also be excluded from the study since development and decline in movement performance and the associated brain activation is out of the scope of the present study.
  2. Normal subjects with MRI findings consistent with organic brain lesions such as brain tumors, stroke, trauma or AVMs will be excluded.
  3. Normal subjects with a history of significant medical disorders such as cancers, or requiring continuous treatment with drugs will be excluded.
  4. Subjects with mental disorders will be excluded.
  5. We will not scan pregnant women because safety of high magnetic field to fetus is not established. Therefore, we will administer a urine pregnancy test for any female subjects of childbearing potential 24 hours prior to functional MRI scan. Pregnant women will not be excluded from the EEG arm of this protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 10, 2001

Study Completion

December 24, 2008

Study Registration Dates

First Submitted

January 9, 2002

First Submitted That Met QC Criteria

January 9, 2002

First Posted (Estimate)

January 10, 2002

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 30, 2017

Last Verified

December 24, 2008

More Information

Terms related to this study

Other Study ID Numbers

  • 020069
  • 02-N-0069

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe